Avantax Planning Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-50	Closed	-$4K	–	311
2018 Q3	$4K	Buy	+50	New	+$4K	﹤0.01%	1140
2018 Q2	–	Sell	-61	Closed	-$7K	–	282
2018 Q1	$7K	Buy	+61	New	+$7K	﹤0.01%	1178